Hem › Triplenegativ bröstcancer › Kalifornien › San Diego
Kliniska studier för Triplenegativ bröstcancer i San Diego, CA
13 studier för Triplenegativ bröstcancer söker deltagare vid platser i och runt San Diego (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RekryterarFas 1
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla · 11 mi bort
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekryterarFas 1/2
- University of San Diego Moores Cancer Center, La Jolla · 11 mi bort
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RekryterarObservationsstudie
- University of California San Diego, La Jolla · 11 mi bort
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
RekryterarFas 3
- Scripps Cancer Center ( Site 0052), La Jolla · 11 mi bort
Intratumoral N17350 in Advanced Solid Tumors
RekryterarFas 1/2
- Scripps Clinic Torrey Pines - La Jolla, San Diego
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
RekryterarFas 1
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla · 11 mi bort
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
RekryterarFas 1
- UC San Diego Moores Cancer Center, La Jolla · 11 mi bort
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RekryterarFas 1/2
- University of California, San Diego; Moores Cancer Center, San Diego
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
RekryterarFas 2
- University of California San Diego, La Jolla · 11 mi bort
A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs
RekryterarFas 1
- UCSD Moores Cancer Center, La Jolla · 11 mi bort
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
RekryterarFas 1/2
- UCSD Moores Cancer Center, La Jolla · 11 mi bort
A Beta-only IL-2 ImmunoTherapY Study
RekryterarFas 1/2
- Sharp Memorial Hospital, San Diego
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
RekryterarFas 1
- UC San Diego Moores Cancer Center, La Jolla · 11 mi bort
Triplenegativ bröstcancer-studier i andra städer
- Houston, TX42 studier
- New York City, NY31 studier
- Nashville, TN28 studier
- Los Angeles, CA27 studier
- Boston, MA26 studier
- San Antonio, TX23 studier
- St. Louis, MO21 studier
- Arlington, VA20 studier
- Atlanta, GA20 studier
- Dallas, TX18 studier
- Chicago, IL16 studier
- Columbus, OH16 studier
Andra studier i San Diego
- Icke-småcellig lungcancer48 studier
- Bröstcancer41 studier
- Cancer (alla typer)32 studier
- Prostatacancer31 studier
- Metastaserande cancer30 studier
- Kolorektal cancer25 studier
- Äggstockscancer24 studier
- Bukspottkörtelcancer24 studier
- Lungcancer23 studier
- Övervikt23 studier
- Hjärtsvikt23 studier
- Depression21 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.